1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Epigenetics Drugs & Diagnostic Technologies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Epigenetics Drugs 1.2.3 Epigenetics Diagnostic Technologies 1.3 Market by Application 1.3.1 Global Epigenetics Drugs & Diagnostic Technologies Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Research Institution 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Epigenetics Drugs & Diagnostic Technologies Market Perspective (2016-2027) 2.2 Epigenetics Drugs & Diagnostic Technologies Growth Trends by Regions 2.2.1 Epigenetics Drugs & Diagnostic Technologies Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Epigenetics Drugs & Diagnostic Technologies Historic Market Share by Regions (2016-2021) 2.2.3 Epigenetics Drugs & Diagnostic Technologies Forecasted Market Size by Regions (2022-2027) 2.3 Epigenetics Drugs & Diagnostic Technologies Industry Dynamic 2.3.1 Epigenetics Drugs & Diagnostic Technologies Market Trends 2.3.2 Epigenetics Drugs & Diagnostic Technologies Market Drivers 2.3.3 Epigenetics Drugs & Diagnostic Technologies Market Challenges 2.3.4 Epigenetics Drugs & Diagnostic Technologies Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Epigenetics Drugs & Diagnostic Technologies Players by Revenue 3.1.1 Global Top Epigenetics Drugs & Diagnostic Technologies Players by Revenue (2016-2021) 3.1.2 Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share by Players (2016-2021) 3.2 Global Epigenetics Drugs & Diagnostic Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Epigenetics Drugs & Diagnostic Technologies Revenue 3.4 Global Epigenetics Drugs & Diagnostic Technologies Market Concentration Ratio 3.4.1 Global Epigenetics Drugs & Diagnostic Technologies Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Epigenetics Drugs & Diagnostic Technologies Revenue in 2020 3.5 Epigenetics Drugs & Diagnostic Technologies Key Players Head office and Area Served 3.6 Key Players Epigenetics Drugs & Diagnostic Technologies Product Solution and Service 3.7 Date of Enter into Epigenetics Drugs & Diagnostic Technologies Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Epigenetics Drugs & Diagnostic Technologies Breakdown Data by Type 4.1 Global Epigenetics Drugs & Diagnostic Technologies Historic Market Size by Type (2016-2021) 4.2 Global Epigenetics Drugs & Diagnostic Technologies Forecasted Market Size by Type (2022-2027) 5 Epigenetics Drugs & Diagnostic Technologies Breakdown Data by Application 5.1 Global Epigenetics Drugs & Diagnostic Technologies Historic Market Size by Application (2016-2021) 5.2 Global Epigenetics Drugs & Diagnostic Technologies Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Epigenetics Drugs & Diagnostic Technologies Market Size (2016-2027) 6.2 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Type 6.2.1 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2021) 6.2.2 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2022-2027) 6.2.3 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2027) 6.3 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Application 6.3.1 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2021) 6.3.2 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2022-2027) 6.3.3 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2027) 6.4 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Country 6.4.1 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2016-2021) 6.4.2 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Epigenetics Drugs & Diagnostic Technologies Market Size (2016-2027) 7.2 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Type 7.2.1 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2021) 7.2.2 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2022-2027) 7.2.3 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2027) 7.3 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Application 7.3.1 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2021) 7.3.2 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2022-2027) 7.3.3 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2027) 7.4 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Country 7.4.1 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2016-2021) 7.4.2 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size (2016-2027) 8.2 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Type 8.2.1 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2027) 8.3 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Application 8.3.1 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2027) 8.4 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Region 8.4.1 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size (2016-2027) 9.2 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Type 9.2.1 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2021) 9.2.2 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2022-2027) 9.2.3 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2027) 9.3 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Application 9.3.1 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2021) 9.3.2 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2022-2027) 9.3.3 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2027) 9.4 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Country 9.4.1 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2016-2021) 9.4.2 Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size (2016-2027) 10.2 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Type 10.2.1 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2027) 10.3 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Application 10.3.1 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2027) 10.4 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Country 10.4.1 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 4SC 11.1.1 4SC Company Details 11.1.2 4SC Business Overview 11.1.3 4SC Epigenetics Drugs & Diagnostic Technologies Introduction 11.1.4 4SC Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) 11.1.5 4SC Recent Development 11.2 Acetylon Pharmaceuticals 11.2.1 Acetylon Pharmaceuticals Company Details 11.2.2 Acetylon Pharmaceuticals Business Overview 11.2.3 Acetylon Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Introduction 11.2.4 Acetylon Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) 11.2.5 Acetylon Pharmaceuticals Recent Development 11.3 Astex Pharmaceuticals 11.3.1 Astex Pharmaceuticals Company Details 11.3.2 Astex Pharmaceuticals Business Overview 11.3.3 Astex Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Introduction 11.3.4 Astex Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) 11.3.5 Astex Pharmaceuticals Recent Development 11.4 CellCentric 11.4.1 CellCentric Company Details 11.4.2 CellCentric Business Overview 11.4.3 CellCentric Epigenetics Drugs & Diagnostic Technologies Introduction 11.4.4 CellCentric Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) 11.4.5 CellCentric Recent Development 11.5 Celleron Therapeutics 11.5.1 Celleron Therapeutics Company Details 11.5.2 Celleron Therapeutics Business Overview 11.5.3 Celleron Therapeutics Epigenetics Drugs & Diagnostic Technologies Introduction 11.5.4 Celleron Therapeutics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) 11.5.5 Celleron Therapeutics Recent Development 11.6 Celgene Corporation 11.6.1 Celgene Corporation Company Details 11.6.2 Celgene Corporation Business Overview 11.6.3 Celgene Corporation Epigenetics Drugs & Diagnostic Technologies Introduction 11.6.4 Celgene Corporation Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) 11.6.5 Celgene Corporation Recent Development 11.7 Chroma Therapeutics 11.7.1 Chroma Therapeutics Company Details 11.7.2 Chroma Therapeutics Business Overview 11.7.3 Chroma Therapeutics Epigenetics Drugs & Diagnostic Technologies Introduction 11.7.4 Chroma Therapeutics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) 11.7.5 Chroma Therapeutics Recent Development 11.8 Epigentek Group 11.8.1 Epigentek Group Company Details 11.8.2 Epigentek Group Business Overview 11.8.3 Epigentek Group Epigenetics Drugs & Diagnostic Technologies Introduction 11.8.4 Epigentek Group Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) 11.8.5 Epigentek Group Recent Development 11.9 Eisai 11.9.1 Eisai Company Details 11.9.2 Eisai Business Overview 11.9.3 Eisai Epigenetics Drugs & Diagnostic Technologies Introduction 11.9.4 Eisai Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) 11.9.5 Eisai Recent Development 11.10 EnVivo Pharmaceuticals 11.10.1 EnVivo Pharmaceuticals Company Details 11.10.2 EnVivo Pharmaceuticals Business Overview 11.10.3 EnVivo Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Introduction 11.10.4 EnVivo Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) 11.10.5 EnVivo Pharmaceuticals Recent Development 11.11 Base Genomics 11.11.1 Base Genomics Company Details 11.11.2 Base Genomics Business Overview 11.11.3 Base Genomics Epigenetics Drugs & Diagnostic Technologies Introduction 11.11.4 Base Genomics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) 11.11.5 Base Genomics Recent Development 11.12 Oryzon Genomics 11.12.1 Oryzon Genomics Company Details 11.12.2 Oryzon Genomics Business Overview 11.12.3 Oryzon Genomics Epigenetics Drugs & Diagnostic Technologies Introduction 11.12.4 Oryzon Genomics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) 11.12.5 Oryzon Genomics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Epigenetics Drugs & Diagnostic Technologies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Epigenetics Drugs Table 3. Key Players of Epigenetics Diagnostic Technologies Table 4. Global Epigenetics Drugs & Diagnostic Technologies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Epigenetics Drugs & Diagnostic Technologies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Epigenetics Drugs & Diagnostic Technologies Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Regions (2016-2021) Table 8. Global Epigenetics Drugs & Diagnostic Technologies Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Regions (2022-2027) Table 10. Epigenetics Drugs & Diagnostic Technologies Market Trends Table 11. Epigenetics Drugs & Diagnostic Technologies Market Drivers Table 12. Epigenetics Drugs & Diagnostic Technologies Market Challenges Table 13. Epigenetics Drugs & Diagnostic Technologies Market Restraints Table 14. Global Epigenetics Drugs & Diagnostic Technologies Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Players (2016-2021) Table 16. Global Top Epigenetics Drugs & Diagnostic Technologies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epigenetics Drugs & Diagnostic Technologies as of 2020) Table 17. Ranking of Global Top Epigenetics Drugs & Diagnostic Technologies Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Epigenetics Drugs & Diagnostic Technologies Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Epigenetics Drugs & Diagnostic Technologies Product Solution and Service Table 21. Date of Enter into Epigenetics Drugs & Diagnostic Technologies Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million) Table 24. Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share by Type (2016-2021) Table 25. Global Epigenetics Drugs & Diagnostic Technologies Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Epigenetics Drugs & Diagnostic Technologies Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share by Application (2016-2021) Table 29. Global Epigenetics Drugs & Diagnostic Technologies Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million) Table 32. North America Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2021) (US$ Million) Table 34. North America Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2022-2027) & (US$ Million) Table 61. 4SC Company Details Table 62. 4SC Business Overview Table 63. 4SC Epigenetics Drugs & Diagnostic Technologies Product Table 64. 4SC Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million) Table 65. 4SC Recent Development Table 66. Acetylon Pharmaceuticals Company Details Table 67. Acetylon Pharmaceuticals Business Overview Table 68. Acetylon Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Product Table 69. Acetylon Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million) Table 70. Acetylon Pharmaceuticals Recent Development Table 71. Astex Pharmaceuticals Company Details Table 72. Astex Pharmaceuticals Business Overview Table 73. Astex Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Product Table 74. Astex Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million) Table 75. Astex Pharmaceuticals Recent Development Table 76. CellCentric Company Details Table 77. CellCentric Business Overview Table 78. CellCentric Epigenetics Drugs & Diagnostic Technologies Product Table 79. CellCentric Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million) Table 80. CellCentric Recent Development Table 81. Celleron Therapeutics Company Details Table 82. Celleron Therapeutics Business Overview Table 83. Celleron Therapeutics Epigenetics Drugs & Diagnostic Technologies Product Table 84. Celleron Therapeutics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million) Table 85. Celleron Therapeutics Recent Development Table 86. Celgene Corporation Company Details Table 87. Celgene Corporation Business Overview Table 88. Celgene Corporation Epigenetics Drugs & Diagnostic Technologies Product Table 89. Celgene Corporation Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million) Table 90. Celgene Corporation Recent Development Table 91. Chroma Therapeutics Company Details Table 92. Chroma Therapeutics Business Overview Table 93. Chroma Therapeutics Epigenetics Drugs & Diagnostic Technologies Product Table 94. Chroma Therapeutics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million) Table 95. Chroma Therapeutics Recent Development Table 96. Epigentek Group Company Details Table 97. Epigentek Group Business Overview Table 98. Epigentek Group Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million) Table 99. Epigentek Group Recent Development Table 100. Eisai Company Details Table 101. Eisai Business Overview Table 102. Eisai Epigenetics Drugs & Diagnostic Technologies Product Table 103. Eisai Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million) Table 104. Eisai Recent Development Table 105. EnVivo Pharmaceuticals Company Details Table 106. EnVivo Pharmaceuticals Business Overview Table 107. EnVivo Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Product Table 108. EnVivo Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million) Table 109. EnVivo Pharmaceuticals Recent Development Table 110. Base Genomics Company Details Table 111. Base Genomics Business Overview Table 112. Base Genomics Epigenetics Drugs & Diagnostic Technologies Product Table 113. Base Genomics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million) Table 114. Base Genomics Recent Development Table 115. Oryzon Genomics Company Details Table 116. Oryzon Genomics Business Overview Table 117. Oryzon Genomics Epigenetics Drugs & Diagnostic Technologies Product Table 118. Oryzon Genomics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) & (US$ Million) Table 119. Oryzon Genomics Recent Development Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Type: 2020 VS 2027 Figure 2. Epigenetics Drugs Features Figure 3. Epigenetics Diagnostic Technologies Features Figure 4. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Application: 2020 VS 2027 Figure 5. Hospital Case Studies Figure 6. Research Institution Case Studies Figure 7. Others Case Studies Figure 8. Epigenetics Drugs & Diagnostic Technologies Report Years Considered Figure 9. Global Epigenetics Drugs & Diagnostic Technologies Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Epigenetics Drugs & Diagnostic Technologies Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Regions: 2020 VS 2027 Figure 12. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Regions (2022-2027) Figure 13. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Players in 2020 Figure 14. Global Top Epigenetics Drugs & Diagnostic Technologies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epigenetics Drugs & Diagnostic Technologies as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Epigenetics Drugs & Diagnostic Technologies Revenue in 2020 Figure 16. Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share by Type (2016-2021) Figure 17. Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share by Type (2022-2027) Figure 18. North America Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Epigenetics Drugs & Diagnostic Technologies Market Share by Type (2016-2027) Figure 20. North America Epigenetics Drugs & Diagnostic Technologies Market Share by Application (2016-2027) Figure 21. North America Epigenetics Drugs & Diagnostic Technologies Market Share by Country (2016-2027) Figure 22. United States Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Epigenetics Drugs & Diagnostic Technologies Market Share by Type (2016-2027) Figure 26. Europe Epigenetics Drugs & Diagnostic Technologies Market Share by Application (2016-2027) Figure 27. Europe Epigenetics Drugs & Diagnostic Technologies Market Share by Country (2016-2027) Figure 28. Germany Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Share by Type (2016-2027) Figure 36. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Share by Application (2016-2027) Figure 37. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Share by Region (2016-2027) Figure 38. China Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Epigenetics Drugs & Diagnostic Technologies Market Share by Type (2016-2027) Figure 46. Latin America Epigenetics Drugs & Diagnostic Technologies Market Share by Application (2016-2027) Figure 47. Latin America Epigenetics Drugs & Diagnostic Technologies Market Share by Country (2016-2027) Figure 48. Mexico Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Share by Type (2016-2027) Figure 52. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Share by Application (2016-2027) Figure 53. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Share by Country (2016-2027) Figure 54. Turkey Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. 4SC Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) Figure 58. Acetylon Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) Figure 59. Astex Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) Figure 60. CellCentric Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) Figure 61. Celleron Therapeutics Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) Figure 62. Celgene Corporation Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) Figure 63. Chroma Therapeutics Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) Figure 64. Epigentek Group Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) Figure 65. Eisai Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) Figure 66. EnVivo Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) Figure 67. Base Genomics Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) Figure 68. Oryzon Genomics Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2016-2021) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

4SC Acetylon Pharmaceuticals Astex Pharmaceuticals CellCentric Celleron Therapeutics Celgene Corporation Chroma Therapeutics Epigentek Group Eisai EnVivo Pharmaceuticals Base Genomics Oryzon Genomics